Ballwin, MO, United States of America

Kah Tiong Kuan

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mallinckrodt, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kah Tiong Kuan. Retrieved from https://idiyas.com/inventor/kah-tiong-kuan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kah Tiong Kuan

Introduction

Kah Tiong Kuan is an accomplished inventor based in Ballwin, MO (US). He has made significant contributions to the field of nanoparticle technology, particularly in drug delivery systems. His innovative work has led to the development of a unique patent that enhances the capabilities of nanoparticles.

Latest Patents

Kah Tiong Kuan holds a patent for "Remote assembly of targeted nanoparticles using H-phosphate ENE/-YNE hydrophosphonylation reactions." This invention provides phosphonate compounds and methods for preparing these compounds, which allow for increased capability to modify nanoparticles for targeted drug delivery applications. This advancement has the potential to revolutionize how medications are delivered within the body.

Career Highlights

Kah Tiong Kuan is currently employed at Mallinckrodt, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in nanoparticle technology has positioned him as a valuable asset to his team and the company.

Collaborations

Kah Tiong Kuan collaborates with Thomas Edward Rogers, leveraging their combined expertise to push the boundaries of nanoparticle research and development.

Conclusion

Kah Tiong Kuan's contributions to nanoparticle technology and drug delivery systems exemplify the impact of innovation in the medical field. His work continues to pave the way for advancements that could significantly improve patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…